Logo

Cian Healthcare Limited Share Price

BSE: 542678
|
Pharmaceuticals
₹ 8.26
+0.00 (0.00%)
1D
Last updated 10 Apr, 2026, 09:46 IST

--
0.00% up today
--
1D LOW
1D HIGH

Cian Healthcare Limited Returns Calculator

Open
--
High
--
Low
--
Prev. close
₹8.26

Circuit
L
H
₹7.85
₹8.67
52-week
L
H
₹3.11
₹8.26

Cian Healthcare Limited Shareholder Returns

Cian Healthcare Limited Share Price History

Mkt Cap Cr
0.00

P/E

P/B
1.00

ROE

D/E
0.66

ROCE

Div. Yield
0.00%

EPS(TTM)
-8.41
Turnover
0.74

EV/EBITDA

Net Margin
0.00%

Op. Margin
0.00%

ROA

Quick Ratio
0.00

Curr. Ratio
1.73
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Cian Healthcare outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Cian Healthcare appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Cian Healthcare earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

Cian Healthcare Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹30.80₹61.70₹68.59₹77.87
Other Income₹0.27₹0.44₹0.62₹0.54
Total Revenue₹31.07₹62.14₹69.21₹78.41
Total Expenses₹44.81₹62.09₹67.33₹84.34
Profit Before Tax-₹26.00₹0.05₹1.99-₹6.00
Tax-₹0.02-₹0.80-₹0.04-₹0.47
Profit After Tax-₹25.98₹0.85₹2.03-₹5.53
EPS - Basic-₹10.39₹0.34₹0.81-₹2.21
EPS - Diluted-₹10.39₹0.34₹0.81-₹2.21

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹25.98₹0.85₹2.03-₹5.53
Income before WC changes-₹19.21₹10.98₹12.12₹4.13
Change in Assets₹18.42-₹4.80-₹2.40-₹15.18
Change in Liabilities₹21.54₹5.59-₹4.88₹19.62
Change in WC₹39.96₹0.78-₹7.28₹4.45
Cash flow from Operations₹20.75₹11.76₹4.84₹8.58
Cash flow from Investing-₹0.25-₹1.46₹2.55₹1.40
Cash flow from Financing-₹3.92-₹10.44-₹7.41-₹10.96
Total Cash Flow₹16.58-₹0.14-₹0.01-₹0.98
Cash (Start of the year)₹1.19₹1.33₹1.34₹2.32
Cash (End of the year)₹17.77₹1.19₹1.33₹1.34

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹85.22₹89.43₹86.24₹86.98
Current Assets₹70.84₹71.74₹74.24₹78.96
Total Assets₹156.06₹161.18₹160.48₹165.94
Current Liabilities₹114.49₹66.11₹65.27₹69.45
Net Current Asset-₹43.65₹5.63₹8.98₹9.51
Non-Current Liabilities₹9.21₹36.73₹37.73₹41.03
Equity Capital₹32.36₹58.33₹57.49₹55.46
Total Equity & Liabilities₹156.06₹161.18₹160.48₹165.94

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹30.88₹58.75₹67.56₹64.10
Other Income₹0.25₹1.06₹0.54₹0.47
Total Revenue₹31.14₹59.81₹68.10₹64.57
Total Expenses₹38.56₹59.80₹66.93₹66.88
Profit Before Tax-₹19.67₹0.01₹1.20-₹2.38
Tax-₹0.02-₹0.38₹0.12-₹0.10
Profit After Tax-₹19.66₹0.39₹1.08-₹2.28
EPS - Basic-₹7.86₹0.16₹0.43-₹0.96
EPS - Diluted-₹7.86₹0.16₹0.43-₹0.96

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹19.66₹0.39₹1.08-₹2.28
Income before WC changes-₹15.54₹8.21₹8.68₹4.82
Change in Assets₹15.76-₹5.03-₹6.75-₹10.61
Change in Liabilities₹20.43₹3.76₹0.22₹11.30
Change in WC₹36.19-₹1.26-₹6.53₹0.69
Cash flow from Operations₹20.66₹6.94₹2.15₹5.51
Cash flow from Investing-₹0.27-₹0.93-₹1.08-₹3.85
Cash flow from Financing-₹3.46-₹6.41-₹1.17-₹2.65
Total Cash Flow₹16.93-₹0.40-₹0.10-₹0.99
Cash (Start of the year)₹0.73₹1.13₹1.22₹2.21
Cash (End of the year)₹17.66₹0.73₹1.13₹1.22

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹75.70₹78.13₹72.39₹70.99
Current Assets₹66.97₹64.76₹68.24₹68.79
Total Assets₹142.68₹142.89₹140.63₹139.78
Current Liabilities₹97.59₹56.16₹57.99₹56.87
Net Current Asset-₹30.62₹8.60₹10.25₹11.92
Non-Current Liabilities₹2.93₹24.92₹21.22₹22.57
Equity Capital₹42.16₹61.81₹61.42₹60.35
Total Equity & Liabilities₹142.68₹142.89₹140.63₹139.78
* All values are in INR Crore
Qty
Bid
96000
8.67
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 96000
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
1
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

ATR (14)
0.39
Neutral

STOCH(9,6)
100
Bearish

ROC(12)
4.96
Bullish

WillR(14)
0
Bearish
Period
Simple value
Exponential vaue

5D
8.07
0

10D
8.07
0

20D
8.07
0

50D
8.07
0

100D
8.07
0

About Cian Healthcare Limited

Cian Healthcare Limited logo
ISIN
INE05BN01027
Sector Market Cap

Cian Healthcare Limited is an India-based company, which is engaged in manufacturing of Pharmaceuticals, OTCs, Supplements and Veterinary products. The Company is engaged in manufacturing multiple lines-tablets, capsules, soft gels, liquid orals, ointments/ creams and sachets. Its portfolio comprises gynaecology, haematinic, cardio- diabetic, orthopaedic, paediatric, derma-cosmetic, antibiotic, CNS, vitamins and nutrient products. It is also engaged in the business of manufacturing cosmetic products. The Company's services include pharma visual aid (book or spiral) design and printing, pharma literature design and printing, pharma monographs/ reference folders, LBL’s/ reminder cards design, pharma poster design, pharmaceutical carton/ catch cover designing, corporate identity design, advertising design, product information leaflet, and brand communication. The Company's subsidiary includes Dr. Smith Biotech Private Limited.

Cian Healthcare Limited Financial Highlights

  • Revenue: Cian Healthcare Limited reported revenue of ₹29.47 crore in FY26 vs ₹31.07 crore in FY25. It showed a decrease of 5.15% on a yearly basis.
  • Operating Profit: Cian Healthcare Limited reported an operating loss of ₹23.18 crore in FY26 vs ₹26.00 crore in FY25. It showed an increase of 10.85% on a year-on-year basis.
  • Net Profit: Cian Healthcare Limited reported a net loss of ₹23.29 crore in FY26 vs ₹25.98 crore in FY25. It showed an increase of 10.35% on a yearly basis.
Know more
Promoters
95.00%
FII
0.00%
Other DII
0.00%
Retail and other
5.00%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
Cian Healthcare Limited logo
Cian Healthcare Limited
Pharmaceuticals
Add Stock
Add Another

FAQs on Cian Healthcare Limited Share Price